AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy-Reference-Cited by-同舟云学术

AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy

Published:2011-11-29 Issue:10 Volume:72 Page:1133-1139
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Rosenbaum Eli,Begum Shahnaz,Brait Mariana,Zahurak Marianna,Maldonado Leonel,Mangold Leslie A.,Eisenberger Mario A.,Epstein Jonathan I.,Partin Alan W.,Sidransky David,Hoque Mohammad O.

Publisher

Wiley

Subject

Urology,Oncology

Reference28 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer;Han;J Urol,2003

3. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era;Kuban;Int J Radiat Oncol Biol Phys,2003

4. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: A large single-institution experience with radical prostatectomy and external-beam radiotherapy;Kupelian;J Clin Oncol,2002

5. Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: The Seattle experience;Sylvester;Int J Radiat Oncol Biol Phys,2003

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome 6;Cancer Genes;2023-07-09

2. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients;Frontiers in Oncology;2023-02-28

3. Relation of the methylation state of RUNX3 and p16 gene promoters with hepatocellular carcinoma in Egyptian patients;Egyptian Journal of Medical Human Genetics;2022-03-06

4. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma;Pharmacological Research;2021-02

5. Advances in Prognostic Methylation Biomarkers for Prostate Cancer;Cancers;2020-10-15